Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials
BackgroundAlthough gonadotropin-releasing hormone (GnRH) agonist has been introduced as a beneficial luteal phase support (LPS), the optimal strategy of GnRH agonist remains unclear. This network meta-analysis was therefore performed to determine the comparative efficacy and safety of multiple-dose...
Main Authors: | Yang Liu, Yanzhi Wu, Zhengmei Pan, Fangjie Jiang, Youhui Lu, Yushi Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.802688/full |
Similar Items
-
Effects of gonadotropin-releasing hormone agonist (GnRH-a) as luteal phase support in intracytoplasmic sperm injection (ICSI) cycles: a randomized controlled trial
by: Nasrin Saharkhiz, et al.
Published: (2020-06-01) -
GnRH agonist as a luteal support in IVF cycle: mini-review—is there a role?
by: Hasan Maghraby, et al.
Published: (2022-07-01) -
Effect of luteal-phase GnRH agonist on frozen-thawed embryo transfer during artificial cycles: a randomised clinical pilot study
by: Yanghong Liu, et al.
Published: (2023-06-01) -
Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg
by: Alamtaj Samsami, et al.
Published: (2020-11-01) -
The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study
by: Ying Zhang, et al.
Published: (2022-09-01)